US Broker Ratings

Solventum Corporation (SOLV) Stock Analysis: Unveiling a 6.91% Upside in the Healthcare Sector

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, has captured investor attention with its compelling growth potential and diverse portfolio. Specializing in medical instruments and supplies, the..

Molina Healthcare Inc (MOH) Stock Analysis: Evaluating a 10.33% Upside Potential Within the Healthcare Sector

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, presents an intriguing opportunity for investors seeking exposure in the managed healthcare services sector. With its focus..

Abbott Laboratories (ABT) Stock Analysis: Strong Buy Ratings Amid 23.68% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, commands significant attention from investors with its robust market presence and diverse product offerings. With a sprawling portfolio that spans..

Waters Corporation (WAT) Stock Analysis: Navigating a 113.4% Revenue Growth in Healthcare Diagnostics

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, is making waves in the diagnostics and research industry. With its headquarters in Milford, Massachusetts, the company has carved..

Qiagen N.V. (QGEN) Stock Analysis: Evaluating Growth Potential Amid Robust Analyst Ratings

Investors eyeing opportunities in the healthcare sector might want to take a closer look at Qiagen N.V. (NYSE: QGEN), a major player in the diagnostics and research industry. Headquartered in..

Exelixis, Inc. (EXEL) Stock Analysis: Understanding the Growth Potential and Analyst Consensus

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, continues to capture investor interest with its focus on pioneering cancer treatments. The company’s robust position in the healthcare..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 28% Potential Upside in the Healthcare Sector

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a formidable player in the medical care facilities industry, boasting a market capitalization of $10.01 billion. Established in 1999 and headquartered in..

Avantor, Inc. (AVTR) Stock Analysis: Navigating a Modest Revenue Growth and Analyst Ratings

Avantor, Inc. (AVTR) stands out in the healthcare sector as a key player in the medical instruments and supplies industry. With its roots tracing back to 1904, the company has..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Unveiling a 21.53% Potential Upside

Intuitive Surgical, Inc. (NASDAQ: ISRG), a titan in the healthcare sector, continues to captivate investor attention with its innovative medical instruments, most notably the da Vinci Surgical System. This advanced..

Mettler-Toledo International (MTD) Stock Analysis: Navigating a Competitive Market with Steady Revenue Growth

Mettler-Toledo International Inc. (NYSE: MTD), a key player in the diagnostics and research industry, stands as an intriguing option for investors, particularly in the healthcare sector. With a market capitalization..

Zoetis Inc. (ZTS) Investor Outlook: Exploring a 37.75% Potential Upside in the Healthcare Sector

As a leading player in the healthcare sector, Zoetis Inc. (NYSE: ZTS) is a standout company focused on animal health, offering a comprehensive range of products and services that cater..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Unveiling a 29% Potential Upside for Investors

GE HealthCare Technologies Inc. (NYSE: GEHC) has been making waves in the healthcare sector with its robust portfolio of medical devices and innovative digital solutions. With a market capitalization of..

Henry Schein, Inc. (HSIC) Stock Analysis: Unlocking a 14.59% Upside in the Medical Distribution Sector

Henry Schein, Inc. (NASDAQ: HSIC), a leading player in the healthcare sector, is poised for intriguing growth potential, with a notable 14.59% upside based on the average analyst target price...

Regeneron Pharmaceuticals (REGN): Investor Outlook with a 16% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a prominent player in the biotechnology sector, has captured investor attention with its strong performance metrics and promising growth potential. With a market capitalization of..

Universal Health Services, Inc. (UHS) Stock Analysis: A 10.60% Upside Potential in the Healthcare Sector

Universal Health Services, Inc. (NYSE: UHS), a stalwart in the healthcare industry, offers a compelling opportunity for investors seeking exposure to the medical care facilities sector. As a provider of..

Thermo Fisher Scientific Inc (TMO): Insights into a Healthcare Giant’s Market Position and Growth Potential

Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector, is a company that investors should keep on their radar. With a robust market capitalization of $242.11 billion,..

Penumbra, Inc. (PEN) Investor Outlook: Exploring the 13.95% Potential Upside Amid Strong Revenue Growth

Penumbra, Inc. (PEN), a key player in the medical devices sector, has been catching the eye of investors with its robust growth prospects and innovative product offerings. With a market..

Doximity, Inc. (DOCS) Stock Analysis: Exploring Its 6.22% Potential Upside

Doximity, Inc. (NYSE: DOCS) stands as a noteworthy player in the healthcare sector, particularly within the niche of Health Information Services. This San Francisco-based company has carved out a significant..

Baxter International (BAX) Investor Outlook: 22% Upside Potential Amid Mixed Valuation Metrics

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector specializing in medical instruments and supplies, is positioned at an intriguing juncture for investors. With a market capitalization of..

GSK plc (GSK) Stock Analysis: Unveiling a 26% Potential Upside in the Healthcare Sector

GSK plc (NYSE: GSK), a leading player in the healthcare sector, is positioned in the drug manufacturing industry with a robust market capitalization of $94.23 billion. Known for its extensive..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds